Generics distributor Anda, Inc. has a new owner: Teva Pharma
New York Opioid Trial: Allergan Settlement Leaves Teva as Last Target - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Anda - Crunchbase Company Profile & Funding
Teva's Generic Value Chain Differentiates It from Its Peers
Zydus Healthcare buys 2 ANDAs from Teva - The Economic Times
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
FDA Priority ANDA Review and Teva api support | Teva api
Teva Holds off Huntington's Competitor, Resolves Opioid Cases | BioSpace
Rosiglitazone Maleate and Glimepiride Tablets, 4 mg (base)/1 mg, 4 mg (base)/2 mg, 4 mg (base)/4 mg, 8 mg (base)/2 mg, and 8 mg
Teva issues in line guidance as North American revenue remains flat
Who We Are | AndaNet
Teva buys Anda for $500 million - ISRAEL21c
Allergan sells Anda to Teva for $500 million - CDR – Chain Drug Review
Teva: Dr. Reddy's buys eight ANDAs from Teva for $350 million - The Economic Times
Allergan sells Anda to Teva for $500 million - CDR – Chain Drug Review
Teva Pharmaceuticals USA and Anda, Inc.... - Kids In Distress | Facebook
Teva Pharmaceutical Industries (NYSE: TEVA) Q4 2019 Earnings | AlphaStreet
Dr Reddy's completes acquisition of 8 Teva ANDAs - The Hindu BusinessLine
Teva Takes Aim At First Truvada And Atripla Generics In US :: Generics Bulletin
Teva Pharmaceuticals - Wikipedia
What GSK v. Teva Means for ANDA Skinny Labels
Who We Are | AndaNet
Teva buys Allergan distributor Anda for $500m - Globes
